Even

Even is a medical company aimed at improving the lives of medication users by addressing nutrient imbalances caused by medications. Founded in 2018, the company's slogan, "Enhancing lives by addressing nutrient imbalances caused by medications," encapsulates its mission. Even's founder, Sarah Morgan, identified a common issue among patients: medication-induced nutrient depletions, known as M.I.N.D.™. To tackle this problem, Sarah brought together a multidisciplinary team of physicians, nutritionists, and pharmacists to develop Even, a medical food designed to complement medications and restore the body's balance. The company operates within the Health Care, Health and Wellness, and Nutrition industries, addressing a crucial aspect of overall well-being. In the latest funding round on March 18, 2021, Even successfully secured a $1.50M investment from Align Ventures, Spring Street Group, and GAN Ventures. This financial backing will likely propel Even's efforts to provide innovative solutions to medication-related nutrient imbalances, positioning the company as a promising player in the healthcare industry.